IP Library Granted Patent US 7,440,939
Granted Patent B2
US 7,440,939 · App. 11/436,782 · Granted Oct 21, 2008

System and method for inter-relating multiple data types relating to pharmaceutical products, therapies and companies

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,440,939
App. No.
11/436,782
Granted
Oct 21, 2008
Kind
B2
Abstract

Techniques for inter-relating various types of data from a plurality of dissimilar data sources relating to marketed pharmaceutical products are disclosed. Various data types may be inter-related based on one or more common data features and displayed in a comprehensive format.

Claims (21)

1. A system for inter-relating two or more product attributes to a marketed pharmaceutical product, derived from separate data source with dissimilar data, comprising: (a) a database storing product attribute information for two or more attributes derived from separate data source with dissimilar data that relate to said marketed pharmaceutical product; (b) an input device, coupled to said database, for receiving a request for product attribute information concerning said marketed pharmaceutical product; and (c) a processor, coupled to said database and to said input device, for inter-relating one or more product attribute information items from said database to said marketed pharmaceutical product in accordance with said request.

2. The system of claim 1 , further comprising an output, coupled to said processor, for providing said one or more inter-related product attribute information items in a human readable format.

3. The system of claim 2 , wherein said output comprises a client computer.

4. The system of claim 1 , wherein said product attribute information includes marketed product molecule data.

5. The system of claim 1 , wherein said product attribute information includes information relating to publications discussing said marketed pharmaceutical product.

6. The system of claim 1 , wherein said product attribute information includes physical dollar sales data for said marketed pharmaceutical product.

7. The system of claim 1 , wherein said product attribute information includes marketed pharmaceutical product relationship data.

8. The system of claim 1 , wherein said product attribute information includes marketed pharmaceutical product anatomical therapy classification data.

9. The system of claim 1 , wherein said product attribute information includes marketed pharmaceutical product related research and development product data.

10. The system of claim 1 , wherein said product attribute information includes country marketed data for said marketed pharmaceutical product.

11. The system of claim 1 , wherein said product attribute information includes marketed pharmaceutical product companies data.

12. A method for inter-relating two or more product attributes to a marketed pharmaceutical product derived from separate data source with dissimilar data, comprising the steps of: (a) storing product attribute information for two or more attributes that relate to said marketed pharmaceutical product derived from separate data source with dissimilar data; (b) receiving a request for product attribute information concerning said marketed pharmaceutical product; and (c) inter-relating one or more product attribute information items from said stored product attribute information to said marketed pharmaceutical product in accordance with said request.

13. The method of claim 12 , further comprising the step of displaying said inter-related product attribute information.

14. The method of claim 12 , wherein said step of inter-relating said product attribute information items includes inter-relating marketed product molecule data.

15. The method of claim 12 , wherein said step of inter-relating said product attribute information items includes inter-relating information relating to publications discussing said marketed pharmaceutical product.

16. The method of claim 12 , wherein said step of inter-relating said product attribute information items includes inter-relating physical dollar sales data for said marketed pharmaceutical product.

17. The method of claim 12 , wherein said step of inter-relating said product attribute information items includes inter-relating marketed pharmaceutical product relationship data.

18. The method of claim 12 , wherein said step of inter-relating said product attribute information items includes inter-relating marketed pharmaceutical product anatomical therapy classification data.

19. The method of claim 12 , wherein said step of inter-relating said product attribute information items includes inter-relating marketed pharmaceutical product related research and development product data.

20. The method of claim 12 , wherein said step of inter-relating said product attribute information items includes inter-relating country marketed data for said marketed pharmaceutical product.

21. The method of claim 12 , wherein said step of inter-relating said product attribute information items includes inter-relating marketed pharmaceutical product companies data.

Assignments (10)
SECURITY INTEREST Recorded Mar 12, 2026
From: IMS SOFTWARE SERVICES LTD.; IQVIA INC.; IQVIA RDS INC.; RULES-BASED MEDICINE, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075047/0061 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTIES INADVERTENTLY NOT INCLUDED IN FILING PREVIOUSLY RECORDED AT REEL: 065709 FRAME: 618. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Dec 6, 2023
From: IQVIA INC.; IQVIA RDS INC.; IMS SOFTWARE SERVICES LTD.; Q SQUARED SOLUTIONS HOLDINGS LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065790/0781 →
SECURITY INTEREST Recorded Nov 29, 2023
From: IQVIA INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065709/0618 →
SECURITY INTEREST Recorded Nov 29, 2023
From: IQVIA INC.; IQVIA RDS INC.; IMS SOFTWARE SERVICES LTD.; Q SQUARED SOLUTIONS HOLDINGS LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065710/0253 →
SECURITY INTEREST Recorded May 24, 2023
From: IQVIA INC.; IQVIA RDS INC.; IMS SOFTWARE SERVICES LTD.; Q SQUARED SOLUTIONS HOLDINGS LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 063745/0279 →
CORRECTION BY DECLARATION OF INCORRECTLY LISTED US PATENT NOS. 7440939 AND 7580851 RECORDED ON 1/5/17 UNDER REEL/FRAME 041260/0474 Recorded Mar 9, 2017
From: IMS SOFTWARE SERVICES LTD
To: IMS SOFTWARE SERVICES LTD.
Reel/Frame 041936/0818 →
MERGER AND CHANGE OF NAME Recorded Feb 23, 2017
From: IMS HEALTH INCORPORATED; QUINTILES TRANSNATIONAL CORP.
To: QUINTILES IMS INCORPORATED
Reel/Frame 041791/0233 →
MERGER AND CHANGE OF NAME Recorded Jan 5, 2017
From: IMS HEALTH INCORPORATED; QUINTILES TRANSNATIONAL CORP.
To: QUINTILES IMS INCORPORATED
Reel/Frame 041260/0474 →
SECURITY AGREEMENT Recorded Mar 2, 2010
From: IMS HEALTH INCORPORATED, A DE CORP.; IMS HEALTH LICENSING ASSOCIATES, L.L.C., A DE LLC; IMS SOFTWARE SERVICES LTD., A DE CORP.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 024006/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2006
From: MISTRY, BOP; THOMPSON, SIMON
To: IMS SOFTWARE SERVICES LTD.
Reel/Frame 018364/0105 →